Papyrus Therapeutics
Scientific Advisory Board

Michael J Birrer
Expertise: Genomics of Gynecological Cancers
- Vice-Chancellor of the University of Arkansas for Medical Sciences (UAMS) and Director of the Winthrop P. Rockefeller Cancer Institute
- Former Professor of Medicine at Harvard Medical School and Director of Gynecologic Medical Oncology at Massachusetts General Hospital and the Gynecologic Oncology Research Program at the Dana Farber/Harvard Cancer Center
- Former Chair of the Gynecologic Oncology Working Group, Division of Clinical Sciences, Deputy Branch Chief of Cell and Cancer Biology Branch, NCI

Raoul Chalres Coombes
Expertise: Cancer Drug Development, Translational Oncology, Cancel Clinical Trials
- Professor of Medical Oncology, Imperial College, London and Co-director of the Imperial Breast Cancer Research Program
- Expertise in estrogen receptor function in breast cancer and the specific role of CDK7 in endocrine resistant breast cancer
- Chairman of the International Collaborative Cancer Group
- 5 issued patents relating to breast cancer and novel therapies

Carl-Henrik Heldin
Expertise: Signal Transduction, Ligand and Receptor Tyrosine Kinase Biology
- Professor in Molecular Cell Biology at Uppsala University and ex-Branch Director at the Ludwig Institute for Cancer Research
- Chairman of the Boards of the Nobel Foundation
- Chair of the Boards of the Science for Life Laboratory, and EMBL-node Molecular Infection Biology Sweden
- Ex-Vice president of the European Research Council and Chair of the European Molecular Biology Organization until 2020

Jean Paul Thiery
Expertise: Cell Biology, Epithelial-Mesenchymal Transition, Stem Cell Science
- Professor and Senior Scientist, National Laboratory Guangzhou, China
- Discovered and described Epithelial to Mesenchymal Transition, the mechanism by which cancers spread and metastasize
- Head of translational research at Institut Curie Comprehensive Cancer Center, and head of CNRS laboratory at Ecole Normale Superieure, Paris
- Co-Founder and Chairman of Biocheetah Pte. Ltd, a diagnostics company focused on urological cancers